The surgical treatment of bony metastases of the spine and limbs, The Journal of Bone and Joint Surgery, vol.84, issue.4, pp.521-529, 2002. ,
DOI : 10.1302/0301-620X.84B4.12495
Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure, Journal of Neurosurgery: Spine, vol.7, issue.2, pp.151-160, 2007. ,
DOI : 10.3171/SPI-07/08/151
Palliative Radiotherapy Trials for Bone Metastases: A Systematic Review, Journal of Clinical Oncology, vol.25, issue.11, pp.1423-1436, 2007. ,
DOI : 10.1200/JCO.2006.09.5281
Palliative Radiotherapy for Bone Metastases: An ASTRO Evidence-Based Guideline, International Journal of Radiation Oncology*Biology*Physics, vol.79, issue.4, pp.965-976, 2011. ,
DOI : 10.1016/j.ijrobp.2010.11.026
Prospective evaluation of spinal reirradiation by using stereotactic body radiation therapy, Cancer, vol.34, issue.22 suppl, pp.3509-3516, 2011. ,
DOI : 10.1002/cncr.25918
Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1???2 trial, The Lancet Oncology, vol.13, issue.4, pp.395-402, 2012. ,
DOI : 10.1016/S1470-2045(11)70384-9
Vertebral Compression Fracture After Spine Stereotactic Body Radiotherapy: A Multi-Institutional Analysis With a Focus on Radiation Dose and the Spinal Instability Neoplastic Score, Journal of Clinical Oncology, vol.31, issue.27, pp.3426-3431, 2013. ,
DOI : 10.1200/JCO.2013.50.1411
A Randomized, Placebo-Controlled Trial of Zoledronic Acid in Patients With Hormone-Refractory Metastatic Prostate Carcinoma, JNCI Journal of the National Cancer Institute, vol.94, issue.19, pp.1458-1468, 2002. ,
DOI : 10.1093/jnci/94.19.1458
Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion, Cancer, vol.94, issue.1, pp.36-43, 2004. ,
DOI : 10.1002/cncr.11892
6 Gy) of analgesic radiotherapy plus zoledronate in patients with bone metastases, Clin Transl Oncol, vol.10, pp.281-287, 2008. ,
Synergistic cytotoxic effects of zoledronic acid and radiation in human prostate cancer and myeloma cell lines, International Journal of Radiation Oncology*Biology*Physics, vol.61, issue.2, pp.535-542, 2005. ,
DOI : 10.1016/j.ijrobp.2004.09.065
Novel Aspects of Mevalonate Pathway Inhibitors as Antitumor Agents, Clinical Cancer Research, vol.18, issue.13, pp.3524-3531, 2012. ,
DOI : 10.1158/1078-0432.CCR-12-0489
Induction of ???? T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo, Blood, vol.102, issue.6, pp.2310-2311, 2003. ,
DOI : 10.1182/blood-2003-05-1655
Targeting Human ???? T Cells with Zoledronate and Interleukin-2 for Immunotherapy of Hormone-Refractory Prostate Cancer, Cancer Research, vol.67, issue.15, pp.7450-7457, 2007. ,
DOI : 10.1158/0008-5472.CAN-07-0199
International Spine Radiosurgery Consortium Consensus Guidelines for Target Volume Definition in Spinal Stereotactic Radiosurgery, International Journal of Radiation Oncology*Biology*Physics, vol.83, issue.5, pp.597-605, 2012. ,
DOI : 10.1016/j.ijrobp.2012.03.009
An Overview of Hypofractionation and Introduction to This Issue of Seminars in Radiation Oncology, Seminars in Radiation Oncology, vol.18, issue.4, pp.215-222, 2008. ,
DOI : 10.1016/j.semradonc.2008.04.001
Concurrent sunitinib and stereotactic body radiotherapy for patients with oligometastases, Targeted Oncology, vol.55, issue.1, pp.145-153, 2014. ,
DOI : 10.1007/s11523-013-0280-y
Ablation of a Site of Progression With Stereotactic Body Radiation Therapy Extends Sunitinib Treatment From 14 to 22 Months, Journal of Clinical Oncology, vol.31, issue.23, pp.401-403, 2013. ,
DOI : 10.1200/JCO.2012.47.7455
Radioth??rapie st??r??otaxique hypofractionn??e des m??tastases osseuses, Cancer/Radioth??rapie, vol.18, issue.4, pp.342-349, 2014. ,
DOI : 10.1016/j.canrad.2014.04.005
Stereotactic Body Radiosurgery for Spinal Metastatic Disease: An Evidence-Based Review, International Journal of Surgical Oncology, vol.109, issue.2 c, p.979214, 2011. ,
DOI : 10.1016/S0167-8140(97)00097-2
Concurrent administration of zoledronic acid and irradiation leads to improved bone density, biomechanical strength, and microarchitecture in a mouse model of tumor-induced osteolysis, Journal of Surgical Oncology, vol.16, issue.3, pp.284-290, 2008. ,
DOI : 10.1002/jso.20949
Risk of Fracture After Single Fraction Image-Guided Intensity-Modulated Radiation Therapy to Spinal Metastases, Journal of Clinical Oncology, vol.27, issue.30, pp.5075-5079, 2009. ,
DOI : 10.1200/JCO.2008.19.3508
Early Clinical Experience and Outcome of Helical Tomotherapy for Multiple Metastatic Lesions, International Journal of Radiation Oncology*Biology*Physics, vol.73, issue.5, pp.1517-1524, 2009. ,
DOI : 10.1016/j.ijrobp.2008.07.035
Oligometastases Treated With Stereotactic Body Radiotherapy: Long-Term Follow-Up of Prospective Study, International Journal of Radiation Oncology*Biology*Physics, vol.83, issue.3, pp.878-886, 2012. ,
DOI : 10.1016/j.ijrobp.2011.08.036
Stereotactic body radiotherapy for multisite extracranial oligometastases, Cancer, vol.366, issue.3 suppl, pp.2962-2970, 2012. ,
DOI : 10.1002/cncr.26611
The Measurement of Pain from Metastatic Bone Disease: Capturing the Patient's Experience, Clinical Cancer Research, vol.12, issue.20, pp.6236-6242, 2006. ,
DOI : 10.1158/1078-0432.CCR-06-0988
Symptom Burden: Multiple Symptoms and Their Impact as Patient-Reported Outcomes, JNCI Monographs, vol.2007, issue.37, pp.16-21, 2007. ,
DOI : 10.1093/jncimonographs/lgm005
Stereotactic body radiotherapy: A critical review for nonradiation oncologists, Cancer, vol.77, issue.suppl 3, pp.942-954, 2014. ,
DOI : 10.1002/cncr.28515